158.01
1.29%
2.01
시간 외 거래:
158.51
0.50
+0.32%
Biogen Inc (BIIB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
4.01%
2,290.50
|
2,386.30 | 2,530.30 | 2,456.00 | 2,463.00 |
Cost Of Revenue |
12.31%
542.20
|
618.30 | 659.60 | 592.70 | 662.80 |
Gross Profit |
1.11%
1,748.30
|
1,768.00 | 1,870.70 | 1,863.30 | 1,800.20 |
Operating Expenses
|
13.07%
1,283.50
|
1,476.40 | 2,011.90 | 1,155.20 | 1,361.90 |
Interest Income/Expense |
3.22%
69.20
|
71.50 | 63.80 | 49.10 | 62.50 |
Benefits Costs and Expenses |
12.84%
1,825.70
|
2,094.70 | 2,671.50 | 1,747.90 | 2,024.70 |
Costs And Expenses |
12.84%
1,825.70
|
2,094.70 | 2,671.50 | 1,747.90 | 2,024.70 |
Operating Income/Loss |
59.40%
464.80
|
291.60 | -141.20 | 708.10 | 438.30 |
Income/Loss From Continuing Operations Before Tax |
59.40%
464.80
|
291.60 | -141.20 | 708.10 | 438.30 |
Income Tax Expense/Benefit, Deferred |
44.51%
39.90
|
71.90 | -206.80 | -106.40 | -64.50 |
Income Tax Expense/Benefit |
67.21%
71.40
|
42.70 | -72.90 | 114.80 | 50.70 |
Income/Loss From Continuing Operations After Tax |
58.06%
393.40
|
248.90 | -68.30 | 593.30 | 387.60 |
Net Income/Loss
|
58.06%
393.40
|
248.90 | -68.30 | 593.30 | 387.60 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
-0.80 | -0.20 | 1.70 | -0.30 |
Basic Average Shares |
145.20
|
- | 144.80 | 144.70 | 144.40 |
Diluted Average Shares |
145.80K%
145.90
|
0.10 | 144.80 | 145.50 | 145.20 |
Basic Earnings Per Share |
57.56%
2.71
|
1.72 | -0.47 | 4.09 | 2.69 |
Diluted Earnings Per Share |
57.89%
2.70
|
1.71 | -0.47 | 4.07 | 2.67 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):